EA
ETRM

Emerald Advisers’s EnteroMedics Inc. ETRM Stock Holding History

Emerald Advisers’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51
Closed -$33K – 363
2015
Q2 		$33K Hold
51
– – ﹤0.01% 316
2015
Q1 		$60K Buy
+51
New +$61.5K ﹤0.01% 339
2014
Q2 		– Sell
-33
Closed -$63K – 457
2014
Q1 		$63K Hold
33
– – ﹤0.01% 356
2013
Q4 		$71K Buy
+33
New +$53.2K ﹤0.01% 349

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Advisers's ETRM Position: Q3 2015 in Review

Emerald Advisers sold out of EnteroMedics Inc. (ETRM) in Q3 2015, closing a stake of 51 shares — an estimated $33K sold.

Emerald Advisers first reported a position in ETRM in Q4 2013 and held it in 4 quarters. The position peaked at $71K in Q4 2013. 41 funds tracked by Wall St. Rank hold ETRM as of Q3 2015.

  • Emerald Advisers reported no remaining EnteroMedics Inc. position as of Q3 2015 after selling out during the quarter.
  • Emerald Advisers sold 51 EnteroMedics Inc. shares in Q3 2015, an estimated $33K.
  • Emerald Advisers first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 4 quarters.
  • Emerald Advisers's EnteroMedics Inc. position peaked at $71K in Q4 2013.
  • 41 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2015.

Based on Emerald Advisers's 13F filing for Q3 2015, filed 23 Oct 2015.